down arrow

Kidswell Bio Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3386460004
JPY
211.00
-8 (-3.65%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
5,082.05
2,431.24
2,776.24
1,569.23
996.54
1,077.74
1,021.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,082.05
2,431.24
2,776.24
1,569.23
996.54
1,077.74
1,021.70
Raw Material Cost
3,442.83
1,392.77
1,251.48
552.61
119.57
653.16
413.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
42.49
38.78
34.84
15.46
15.69
5.21
0.00
Selling and Distribution Expenses
843.46
920.71
859.34
1,089.08
882.79
687.82
468.96
Other Expenses
72.54
141.46
118.15
88.76
94.82
89.30
94.52
Total Expenditure (Excl Depreciation)
5,054.17
3,766.83
3,327.17
2,544.75
1,966.23
2,239.13
1,827.27
Operating Profit (PBDIT) excl Other Income
27.9
-1335.6
-550.9000000000001
-975.5
-969.7
-1161.4
-805.6
Other Income
86.13
-15.22
-39.00
440.18
-12.86
-17.09
-10.85
Operating Profit (PBDIT)
114.91
-1,349.89
-589.00
-533.04
-981.55
-1,178.10
-815.70
Interest
42.49
38.78
34.84
15.46
15.69
5.21
0.00
Exceptional Items
1.35
-30.93
-31.45
1.14
-1.45
-6,130.57
-37.98
Gross Profit (PBDT)
1,639.22
1,038.47
1,524.76
1,016.62
876.97
424.58
608.63
Depreciation
0.90
0.92
0.93
2.30
0.99
0.38
0.72
Profit Before Tax
72.87
-1,420.53
-656.22
-549.65
-999.68
-7,314.26
-854.39
Tax
94.01
1.55
1.21
1.21
1.78
2.14
1.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-21.14
-1,422.08
-657.43
-550.86
-1,001.46
-7,316.40
-856.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-21.14
-1,422.08
-657.43
-550.86
-1,001.46
-7,316.40
-856.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-21.14
-1,422.08
-657.43
-550.86
-1,001.46
-7,316.40
-856.29
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,410.98
831.47
1,233.51
1,702.91
1,610.38
1,487.39
2,731.27
Earnings per share (EPS)
-0.52
-40.23
-20.77
-17.86
-34.79
-264.65
-43.84
Diluted Earnings per share
-0.52
-40.23
-20.77
-17.86
-34.79
-264.65
-43.84
Operating Profit Margin (Excl OI)
0.55%
-54.93%
-19.84%
-62.17%
-97.31%
-107.76%
-78.85%
Gross Profit Margin
1.45%
-58.39%
-23.6%
-34.88%
-100.22%
-678.63%
-83.55%
PAT Margin
-0.42%
-58.49%
-23.68%
-35.1%
-100.49%
-678.87%
-83.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 109.04% vs -12.43% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 98.52% vs -116.32% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 102.16% vs -142.67% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 9.54% vs 11.49% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Kidswell Bio Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
5,082.05
54.45
5,027.60
9,233.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,082.05
54.45
5,027.60
9,233.43%
Raw Material Cost
3,442.83
52.88
3,389.95
6,410.65%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
126.09
-126.09
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
42.49
9.51
32.98
346.79%
Selling and Distribution Expenses
843.46
428.13
415.33
97.01%
Other Expenses
72.54
33.40
39.14
117.19%
Total Expenditure (Excl Depreciation)
5,054.17
950.58
4,103.59
431.69%
Operating Profit (PBDIT) excl Other Income
27.88
-896.13
924.01
103.11%
Other Income
86.13
35.90
50.23
139.92%
Operating Profit (PBDIT)
114.91
-824.21
939.12
113.94%
Interest
42.49
9.51
32.98
346.79%
Exceptional Items
1.35
0.00
1.35
Gross Profit (PBDT)
1,639.22
1.56
1,637.66
104,978.21%
Depreciation
0.90
36.02
-35.12
-97.50%
Profit Before Tax
72.87
-869.75
942.62
108.38%
Tax
94.01
2.49
91.52
3,675.50%
Provisions and contingencies
0
0
0.00
Profit After Tax
-21.14
-872.24
851.10
97.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-21.14
-872.24
851.10
97.58%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-21.14
-872.24
851.10
97.58%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,410.98
2,542.41
-1,131.43
-44.50%
Earnings per share (EPS)
-0.52
-108.34
107.82
99.52%
Diluted Earnings per share
-0.52
-108.34
107.82
99.52%
Operating Profit Margin (Excl OI)
0.55%
-1,645.91%
0.00
1,646.46%
Gross Profit Margin
1.45%
-1,531.30%
0.00
1,532.75%
PAT Margin
-0.42%
-1,602.02%
0.00
1,601.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 508.21 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 109.04% vs -12.43% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit -2.11 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 98.52% vs -116.32% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.88 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 102.16% vs -142.67% in Mar 2024

Annual - Interest
Interest 4.25 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 9.54% vs 11.49% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.55%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."